Core Points - The stock price of Yingke Medical (300677) closed at 40.18 yuan on November 24, 2025, marking a 4.17% increase from the previous trading day, with a total market capitalization of 26.31 billion yuan [1] - The company announced the completion of the registration for the reserved portion of its 2025 restricted stock incentive plan, with the grant date set for October 15, 2025, and the listing date on November 26, 2025 [1] - A total of 370,000 shares were granted at a price of 11.25 yuan per share to two senior executives, including the board director and general manager Chen Qiong, and the board vice president Yu Haisheng [1] - Following this grant, the total share capital of the company will increase to 655,163,743 shares, with the incentive plan having four unlock periods corresponding to performance targets from 2026 to 2029, including revenue and net profit metrics [1]
英科医疗(300677)披露2025年限制性股票激励计划预留授予登记完成,11月24日股价上涨4.17%